Method of using exendin and GLP-1 to affect the central nervous

Details Method of using exendin and GLP-1 to affect the central nervous Method of using exendin and GLP-1 to affect the central nervous

1997-03-03

1998-12-08

Allen, Marianne P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 530350, 530399, A61K 3826, C07K 14605

Patent

active

058469370

ABSTRACT:
Agonists of the incretin GLP-1 have been found to have a sedative or anxiolytic effect on the mammalian central nervous system. Additionally, exendin has been found to have an independent sedative effect on the mammalian central nervous system. Conversely, antagonists of GLP-1 increase nervous system activity. The invention relates, in one aspect, to the use of GLP-1 agonists and antagonists to affect the arousal state of the mammalian central nervous system. The invention also relates to novel transgenic mammals in which the GLP-1 receptor gene has been disrupted.

REFERENCES:
patent: 5118666 (1992-06-01), Habener
patent: 5120712 (1992-06-01), Habener
patent: 5424286 (1995-06-01), Eng
patent: 5512549 (1996-04-01), Chen et al.
patent: 5545618 (1996-08-01), Buckley et al.
patent: 5574008 (1996-11-01), Johnson et al.
patent: 5614492 (1997-03-01), Habener
Calvo et al., "Structural Characterization by Affinity Cross-Linking of Glucagon-Like Peptide-1(7-36) Amide Receptor in Rat Brain," Journal of Neurochemistry 64(1):299-306.
Komatsu et al., 1989, "Glucagonostatic and Insulinotropic Action of Glucagonlike Peptide I-(7-36)-Amide," Diabetes 38:902-905.
Larsen et al., 1997, "Distribution of Glucagon-Like Peptide-1 and Other Preproglucagon-Derived Peptides in the Rat Hypothalamus and Brainstem," Neuroscience 77(1):257-270.
Oben et al., 1991, "Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue," Journal of Endocrinology 130:267-272.
Schmidtler et al., 1994, "Rat parietal cell receptors of GLP-1-(7-36) amide: Northern blot, cross-linking, and radioligand binding," American Physiological Society pp. G423-G432.
Weir et al., 1988, "Glucagonlike Peptide I (7-37) Actions on Endocrine Pancreas," pp. 338-341.

Affiliated with

Also associated with

Rating

Method of using exendin and GLP-1 to affect the central nervous does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using exendin and GLP-1 to affect the central nervous , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using exendin and GLP-1 to affect the central nervous will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-177293